NEW YORK, Sept. 26, 2018 /PRNewswire-PRWeb/ -- The Job Research Foundation has announced that it will extend the
The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments for those suffering with Job Syndrome.
Only about 300 cases of Job's Syndrome have been reported since it was first discovered. Patients often suffer from life-threatening complications from basic infections as the disease makes the immune system extremely sensitive to bacteria. People with the syndrome often have multiple, recurring ailments, such as skin infections that cause lesions and boils, and lung infections that cause pneumonia. The disease was named after the Biblical character Job who suffered from boils.
"Our long-term goal is to help advance research to find a cure for Job Syndrome and after several requests we felt it was prudent to extend the deadline to give researchers around the world ample time to submit their application," said Ted Lavin, co-founder of The Job Research Foundation. "In the short term, we hope the research will improve the treatments for patients suffering from this rare disease."
Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. It can be inherited from either parent or result from a new genetic mutation.
Visit https://www.jobresearchfoundation.org/ for additional details about The Job Syndrome Foundation and for information about the Grant Application Process. Job Research Foundation is located at 459 Columbus Avenue in New York. Send emails to firstname.lastname@example.org.
SOURCE Job Research Foundation
Subscribe to our Free Newsletters!